| 1. |
Shaul, P. W. and Anderson, R. G. (1998) Role of plasmalemmal caveolae in signal transduction. Am. J. Physiol.
275(5 Pt 1), L843–L851.
|
| |
| 2. |
Ostrom, R. S. and Insel, P. A. (2004) The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling:
Implications for molecular pharmacology. Br. J. Pharmacol.
143(2), 235–245.
|
| |
| 3. |
Okamoto, T., Schlegel, A., Scherer, P. E., and Lisanti, M. P. (1998) Caveolins, a family of scaffolding proteins for organizing
preassembled signaling complexes at the plasma membrane. J. Biol. Chem.
273(10), 5419–5422.
|
| |
| 4. |
Palade, G. (1953) Fine structure of blood capilaries. J. Appl. Physiol.
24, 1424.
|
| |
| 5. |
Anderson, R. G. (1998) The caveolae membrane system. Annu. Rev. Biochem.
67, 199–225.
|
| |
| 6. |
Rapacciuolo, A., Suvarna, S., Barki-Harrington, L., et al. (2003) Protein kinase A and G protein-coupled receptor kinase phosphorylation
mediates beta-1 adrenergic receptor endocytosis through different pathways. J. Biol. Chem.
278(37), 35,403–35,411.
|
| |
| 7. |
Razani, B., Woodman, S. E., and Lisanti, M. P. (2002) Caveolae: from cell biology to animal physiology. Pharmacol. Rev.
54(3), 431–467.
|
| |
| 8. |
Hooper, N. M. (1999) Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae. Mol. Membr. Biol.
16(2), 145–156 (review).
|
| |
| 9. |
Song, K. S., Scherer, P. E., Tang, Z., et al. (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells.
Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem.
271(25), 15,160–15,165.
|
| |
| 10. |
Tang, Z., Scherer, P. E., Okamoto, T., et al. (1996) Molecular cloning of caveolin-3, a novel member of the caveolin gene
family expressed predominantly in muscle. J. Biol. Chem.
271(4), 2255–2261.
|
| |
| 11. |
Scherer, P. E., Okamoto, T., Chun, M., et al. (1996) Identification, sequence, and expression of caveolin-2 defines a caveolin
gene family. Proc. Natl. Acad. Sci. USA
93(1), 131–135.
|
| |
| 12. |
Scherer, P. E., Lewis, R. Y., Volonté, D., et al. (1997) Cell-type and tissue-specific expression of caveolin-2. Caveolins
1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem.
272(46), 29,337–29,346.
|
| |
| 13. |
Razani, B., Wang, X. B., Engelman, J. A., et al. (2002) Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction
without disruption of caveolae. Mol. Cell Biol.
22(7), 2329–2344.
|
| |
| 14. |
Rybin, V. O., Grabham, P. W., Elouardighi, H., and Steinberg, S. F. (2003) Caveolae-associated proteins in cardiomyocytes:
caveolin-2 expression and interactions with caveolin-3. Am. J. Physiol. Heart Circ. Physiol.
285(1), H325–H332.
|
| |
| 15. |
Lahtinen, U., Honsho, M., Parton, R. G., Simons, K., and Verkade, P. (2003) Involvement of caveolin-2 in caveolar biogenesis
in MDCK cells. FEBS Lett.
538(1–3), 85–88.
|
| |
| 16. |
Ostrom, R. S. (2005) Caveolins muscle their way into the regulation of cell differentiation, development, and function. Focus
on “Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs.
muscle cells.” Am. J. Physiol. Cell Physiol.
288(3), C507–C509.
|
| |
| 17. |
Sowa, G., Pypaert, M., and Sessa, W. C. (2001) Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc. Natl. Acad. Sci. USA
98(24), 14,072–14,077.
|
| |
| 18. |
Williams, T. M. and Lisanti, M. P. (2004) The caveolin proteins. Genome Biol.
5(3), 214.
|
| |
| 19. |
Oh, P. and Schnitzer, J. E. (2001) Segregation of Heterotrimeric G Proteins in Cell Surface Microdomains. G(q) binds caveolin
to concentrate in caveolae, whereas g(i) and g(s) target lipid rafts by default. Mol. Biol. Cell.
12(3), 685–698.
|
| |
| 20. |
Henderson, R. M., Edwardson, J. M., Geisse, N. A., and Saslowsky, D. E. (2004) Lipid rafts: feeling is believing. News Physiol. Sci.
19, 39–43.
|
| |
| 21. |
Oh, P. and Schnitzer, J. E. (1999) Immunoisolation of caveolae with high affinity antibody binding to the oligomeric caveolin
cage. Toward understanding the basis of purification. J. Biol. Chem.
274(33), 23,144–23,154.
|
| |
| 22. |
Ostrom, R. S., Gregorian, C., Drenan, R. M., et al. (2001) Receptor number and caveolar colocalization determine receptor
coupling efficiency to adenylyl cyclase. J. Biol. Chem.
276(45), 42,063–42,069.
|
| |
| 23. |
Smart, E. J. and Anderson, R. G. (2002) Alterations in membrane cholesterol that affect structure and function of caveolae.
Methods Enzymol.
353, 131–139.
|
| |
| 24. |
Ostrom, R. S., Bundey, R. A., and Insel, P. A. (2004) Nitric oxide inhibition of adenylyl cyclase type 6 activity is dependent
upon lipid rafts and caveolin signaling complexes. J. Biol. Chem.
279(19), 19,846–19,853.
|
| |
| 25. |
Orlandi, P. A. and Fishman, P. H. (1998) Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization
and activation through caveolae-like domains. J. Cell Biol.
141(4), 905–915.
|
| |
| 26. |
Schnitzer, J. E., Oh, P., Pinney, E., and Allard, J. (1994) Filipin-sensitive caveolae-mediated transport in endothelium:
reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol.
127(5), 1217–1232.
|
| |
| 27. |
Christian, A. E., Haynes, M. P., Phillips, M. C., and Rothblat, G. H. (1997) Use of cyclodextrins for manipulating cellular
cholesterol content. J. Lipid Res.
38(11), 2264–2272.
|
| |
| 28. |
Head, B. P., Patel, H. H., Roth, D. M., et al. (2005) G-protein-coupled receptor signaling components localize in both sarcolemmal
and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J. Biol. Chem.
280(35), 31,036–31,044.
|
| |
| 29. |
Zacharias, D. A., Violin, J. D., Newton, A. C., and Tsien, R. Y. (2002) Partitioning of lipid-modified monomeric GFPs into
membrane microdomains of live cells. Science
296(5569), 913–916.
|
| |
| 30. |
Ostrom, R. S., Liu, X., Head, B. P., et al. (2002) Localization of adenylyl cyclase isoforms and G protein-coupled receptors
in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains. Mol. Pharmacol.
62(5), 983–992.
|
| |
| 31. |
Capozza, F., Cohen, A. W., Cheung, M. W., et al. (2005) Muscle-specific interaction of caveolin isoforms: differential complex
formation between caveolins in fibroblastic vs. muscle cells. Am. J. Physiol. Cell Physiol.
288(3), C677–C691.
|
| |
| 32. |
Razani, B. and Lisanti, M. P. (2001) Caveolin-deficient mice: insights into caveolar function in human disease. J. Clin. Invest.
108(11), 1553–1561.
|
| |
| 33. |
Smart, E. J., Ying, Y. S., Mineo, C., and Anderson, R. G. (1995) A detergent-free method for purifying caveolae membrane from
tissue culture cells. Proc. Natl. Acad. Sci. USA
92(22), 10,104–10,108.
|
| |
| 34. |
Rybin, V. O., Xu, X., and Steinberg, S. F. (1999) Activated protein kinase C isoforms target to cardiomyocyte caveolae: stimulation
of local protein phosphorylation. Circ. Res.
84(9), 980–988.
|
| |
| 35. |
Pike, L. J. (2003) Lipid rafts: bringing order to chaos. J. Lipid Res.
44(4), 655–667.
|
| |
| 36. |
Rybin, V. O., Xu, X., Lisanti, M. P., and Steinberg, S. F. (2000) Differential targeting of beta-adrenergic receptor subtypes
and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J. Biol. Chem.
275(52), 41,447–41,457.
|
| |